Patents by Inventor Joerg Brandenburg
Joerg Brandenburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11938824Abstract: A hybrid transmission for a vehicle includes a transmission input shaft extending in a transverse direction, at least one countershaft arranged parallel to the transmission input shaft, a clutch device arranged coaxially with respect to the transmission input shaft and which has at least one clutch, and a differential having a differential input gear. A rotational axis of the differential input gear is arranged parallel to the transmission input shaft. The transmission also includes an electric machine having a rotor with a rotor rotational axis arranged parallel to the transmission input shaft and a transmission control device. As viewed in a longitudinal direction perpendicular to the transverse direction, the differential input gear, the transmission input shaft, and a transmission controller including the transmission control device are arranged in succession in the sequence specified.Type: GrantFiled: October 18, 2021Date of Patent: March 26, 2024Assignee: MERCEDES-BENZ GROUP AGInventors: Martin Dengler, Benjamin Bauer, Jan Becker, Markus Brandenburg, Andreas Ertel, Peter Hahn, Tobias Haerter, Elmar Mueller, Jörg Weigold, Timo Maurer, Preetam Birje
-
Patent number: 11926220Abstract: A hybrid transmission for a vehicle includes a transmission input shaft extending in a transverse direction, at least one countershaft arranged parallel to the transmission input shaft, a clutch device arranged coaxially with respect to the transmission input shaft and which has at least one clutch, and a differential having a differential input gear. A rotational axis of the differential input gear is arranged parallel to the transmission input shaft. The transmission also includes an electric machine having a rotor with a rotor rotational axis arranged parallel to the transmission input shaft and a transmission control device. As viewed in a longitudinal direction perpendicular to the transverse direction, the differential input gear, the transmission input shaft, and a transmission controller including the transmission control device are arranged in succession in the sequence specified.Type: GrantFiled: May 31, 2023Date of Patent: March 12, 2024Assignee: MERCEDES-BENZ GROUP AGInventors: Martin Dengler, Benjamin Bauer, Jan Becker, Markus Brandenburg, Andreas Ertel, Peter Hahn, Tobias Haerter, Elmar Mueller, Jörg Weigold, Timo Maurer, Preetam Birje
-
Patent number: 11912132Abstract: A hybrid transmission for a vehicle includes a transmission input shaft extending in a transverse direction, at least one countershaft arranged parallel to the transmission input shaft, a clutch device arranged coaxially with respect to the transmission input shaft and which has at least one clutch, and a differential having a differential input gear. A rotational axis of the differential input gear is arranged parallel to the transmission input shaft. The transmission also includes an electric machine having a rotor with a rotor rotational axis arranged parallel to the transmission input shaft and a transmission control device. As viewed in a longitudinal direction perpendicular to the transverse direction, the differential input gear, the transmission input shaft, and a transmission controller including the transmission control device are arranged in succession in the sequence specified.Type: GrantFiled: May 31, 2023Date of Patent: February 27, 2024Assignee: MERCEDES-BENZ GROUP AGInventors: Martin Dengler, Benjamin Bauer, Jan Becker, Markus Brandenburg, Andreas Ertel, Peter Hahn, Tobias Haerter, Elmar Mueller, Jörg Weigold, Timo Maurer, Preetam Birje
-
Patent number: 9242965Abstract: The present invention is directed to an efficient process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form of formula I wherein R1 and R2 independently denote C1-3-alkyl groups and X? denotes an acid anion, such as the chloride, bromide, tosylate, mesylate or trifluoroacetate anion, with high quality, and a process for synthesis of EGFR tyrosine kinase inhibitors with heterocyclic quinazoline, quinoline or pyrimidopyrimidine core structure, using the acid addition salt I and activated derivatives thereof as intermediates.Type: GrantFiled: December 19, 2014Date of Patent: January 26, 2016Assignee: Boehringer Ingelheim International GmbHInventors: Juncheng Zheng, Da Deng, Guanghua Lv, Jun Yan, Joerg Brandenburg, Jutta Kroeber, Ulrich Scholz
-
Publication number: 20150225395Abstract: The invention relates to a new process for preparing tiotropium salts of general formula 1 wherein X? may have the meanings given in the claims and in the specification.Type: ApplicationFiled: April 23, 2015Publication date: August 13, 2015Inventors: Joerg BRANDENBURG, Waldemar PFRENGLE
-
Publication number: 20150183764Abstract: The present invention is directed to an efficient process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form of formula I wherein R1 and R2 independently denote C1-3-alkyl groups and X? denotes an acid anion, such as the chloride, bromide, tosylate, mesylate or trifluoroacetate anion, with high quality, and a process for synthesis of EGFR tyrosine kinase inhibitors with heterocyclic quinazoline, quinoline or pyrimidopyrimidine core structure, using the acid addition salt I and activated derivatives thereof as intermediates.Type: ApplicationFiled: December 19, 2014Publication date: July 2, 2015Inventors: Juncheng ZHENG, Da Deng, Guanghua LV, Jun Yan, Joerg Brandenburg, Jutta Kroeber, Ulrich Scholz
-
Publication number: 20140323732Abstract: The invention relates to a new process for preparing tiotropium salts of general formula 1 wherein X? may have the meanings given in the claims and in the specification.Type: ApplicationFiled: July 7, 2014Publication date: October 30, 2014Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventors: Joerg BRANDENBURG, Waldemar PFRENGLE
-
Patent number: 8263788Abstract: The invention relates to a method for producing 1,3-dioxolane-2-ones of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1 to R5 have the meanings indicated in the claims and the description. The invention further relates to a method for producing 2-hydroxy carboxylic acid esters of general formula (5) with or without isolation of the intermediate in the form of a derivative of the 1,3-dioxolane-2-one of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1, R2, and R6 have the meanings indicated in the claims and the description. The method according to the invention allows the reaction to take place in very gentle basic conditions, causing fewer secondary reactions and providing a greater yield than reactions in highly polar aprotic solvents. Acid-sensitive and/or temperature-sensitive compounds can be synthesized.Type: GrantFiled: September 3, 2008Date of Patent: September 11, 2012Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Joerg Brandenburg, Rolf Dach, Hanfried Baltes
-
Patent number: 8101763Abstract: The invention relates to a novel method for producing scopine esters of the general formula (1), wherein X—, R, R1, R2, R3, R4, R3?, R4?, R6 and R6? can have the meanings indicated in the claims and in the description.Type: GrantFiled: May 9, 2008Date of Patent: January 24, 2012Assignee: Boehringer Ingelheim International GmbHInventors: Waldemar Pfrengle, Werner Rall, Joerg Brandenburg, Rolf Herter
-
Publication number: 20100305146Abstract: The invention relates to a method for producing 1,3-dioxolane-2-ones of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1 to R5 have the meanings indicated in the claims and the description. The invention further relates to a method for producing 2-hydroxy carboxylic acid esters of general formula (5) with or without isolation of the intermediate in the form of a derivative of the 1,3-dioxolane-2-one of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1, R2, and R6 have the meanings indicated in the claims and the description. The method according to the invention allows the reaction to take place in very gentle basic conditions, causing fewer secondary reactions and providing a greater yield than reactions in highly polar aprotic solvents. Acid-sensitive and/or temperature-sensitive compounds can be synthesized.Type: ApplicationFiled: September 3, 2008Publication date: December 2, 2010Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventors: Joerg Brandenburg, Rolf Dach, Hanfried Baltes
-
Publication number: 20100210844Abstract: The invention relates to a new process for preparing tiotropium salts of general formula 1 wherein X? may have the meanings given in the claims and in the specification.Type: ApplicationFiled: April 29, 2010Publication date: August 19, 2010Applicant: BOEHRINGER INGELHEIM PHARMA GmbH & Co. KGInventors: Joerg Brandenburg, Waldemar Pfrengle
-
Publication number: 20100174067Abstract: The invention relates to a novel method for producing scopine esters of the general formula (1), wherein X—, R, R1, R2, R3, R4, R3?, R4?, R6 and R6? can have the meanings indicated in the claims and in the description.Type: ApplicationFiled: May 9, 2008Publication date: July 8, 2010Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Waldemar Pfrengle, Werner Rall, Joerg Brandenburg, Rolf Herter
-
Publication number: 20100105898Abstract: The invention relates to a new method of preparing scopinium salts of general formula 1 wherein Y? may have the meanings given in the claims and in the specification.Type: ApplicationFiled: January 28, 2008Publication date: April 29, 2010Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventors: Joerg Brandenburg, Werner Belzer
-
Publication number: 20100063289Abstract: The invention relates to a method for producing ammonium hexafluorophosphates of general formula (1) wherein R1, R2, R3 and R4 are defined as in the claims and in the description, said novel ammonium hexafluorophosphates and to the use thereof for producing pharmaceutically active compounds.Type: ApplicationFiled: January 28, 2008Publication date: March 11, 2010Inventor: Joerg Brandenburg
-
Publication number: 20070027320Abstract: The invention relates to a new process for preparing tiotropium salts of general formula 1 wherein X? may have the meanings given in the claims and in the specification.Type: ApplicationFiled: July 24, 2006Publication date: February 1, 2007Applicant: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Joerg Brandenburg, Waldemar Pfrengle
-
Patent number: 7148347Abstract: Disclosed is a process for preparing a macrocyclic compound of the formula (I): which is carried out using an intermediate of the formula (II): wherein W, R1 through R4, D, A and R12 are as defined herein. The compounds of formula (I) are potent active agents for the treatment of hepatitis C virus (HCV) infection.Type: GrantFiled: April 6, 2004Date of Patent: December 12, 2006Assignee: Boehringer Ingelheim International GmbHInventors: Joerg Brandenburg, Kai Donsbach, Hans-Dieter Ecker, Rogelio Perez Frutos, Fabrice Gallou, Dieter Gutheil, Nizar Haddad, Robert Hagenkoetter, Dirk Kemmer, Jutta Kroeber, Thomas Nicola, Juergen Schnaubelt, Michael Schul, Robert Donald Simpson, Xudong Wei, Eric Winter, Yibo Xu, Nathan K. Yee
-
Publication number: 20050049187Abstract: Disclosed is a process for preparing a macrocyclic compound of the formula (I): which is carried out using an intermediate of the formula (II): wherein W, R1 through R4, D, A and R12 are as defined herein. The compounds of formula (I) are potent active agents for the treatment of hepatitis C virus (HCV) infection.Type: ApplicationFiled: April 6, 2004Publication date: March 3, 2005Applicant: Boehringer Ingelheim International GmbHInventors: Joerg Brandenburg, Kai Donsbach, Hans-Dieter Ecker, Rogelio Frutos, Fabrice Gallou, Dieter Gutheil, Nizar Haddad, Robert Hagenkoetter, Dirk Kemmer, Jutta Kroeber, Thomas Nicola, Juergen Schnaubelt, Michael Schul, Robert Simpson, Xudong Wei, Eric Winter, Yibo Xu, Nathan Yee
-
Patent number: 6861547Abstract: The invention relates to a process suitable for large-scale industrial use for preparing compounds of general formula (I) wherein: R1 denotes a group selected from among methyl, ethyl, propyl, cyclopentyl, cyclohexyl, phenyl, benzyl and —C(Me2)phenyl, each of which is optionally mono-, di- or trisubstituted by hydroxy; and, R2 denotes a group selected from among methyl, ethyl, propyl and benzyl.Type: GrantFiled: May 5, 2002Date of Patent: March 1, 2005Assignee: Boehringer Ingelheim International GmbHInventors: Joerg Brandenburg, Rolf Schmid, Rainer Soyka, Ralf Anderskewitz, Rolf Bauer, Rainer Hamm, Jutta Kroeber
-
Patent number: 6747154Abstract: A process for preparing a compound of formula 1 from a compound of formula 2 the process comprising reacting in one step the compound of formula 2 with a compound of formula 3 wherein: X− is chlorine, bromine, iodine, methanesulfonate, or trifluoromethanesulfonate; R1 is hydroxy, C1-C4-alkyl, C1-C4-alkoxy, CF3, or fluorine; Ar is phenyl, naphthyl, thienyl, and furyl, each optionally mono- or disubstituted with one or two groups selected from C1-C4-alkyl, C1-C4-alkoxy, hydroxy, fluorine, chlorine, bromine, or CF3; Y− is chlorine, bromine, iodine, methanesulfonate, or trifluoromethanesulfonate; and R is hydroxy, methoxy, ethoxy, O—N-succinimide, O—N-phthalimide, phenyloxy, nitrophenyloxy, fluorophenyloxy, pentafluorophenyloxy, vinyloxy, 2-allyloxy, —S-methyl, —S-ethyl, or —S-phenyl.Type: GrantFiled: January 9, 2003Date of Patent: June 8, 2004Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Joerg Brandenburg, Waldemar Franz-Augustin Pfrengle, Werner Rall
-
Publication number: 20030232993Abstract: A process for preparing a compound of formula 1 1Type: ApplicationFiled: January 9, 2003Publication date: December 18, 2003Applicant: Boehringer Ingelheim Pharma KGInventors: Joerg Brandenburg, Waldemar Franz-Augustin Pfrengle, Werner Rall